# Legend Biotech Corp: financial statements, quarterly

LEGN · Nasdaq · CIK 1801198 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/legn.md) · [Financials](/companies/legn/financials.md) · [Filings](/companies/legn/filings.md) · [Insiders](/companies/legn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/legn/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-12-31) | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.1](/filings/0001564590-21-017439.md) | [210](/filings/0001564590-23-002041.md) | [83.4](/filings/0001801198-23-000019.md) | [456](/filings/0001801198-24-000021.md) | [689](/filings/0001801198-25-000012.md) | [786](/filings/0001801198-26-000008.md) | [1,278](/filings/0001801198-26-000008.md) | [287](/filings/0001801198-26-000008.md) | [902](/filings/0001801198-26-000008.md) |
| Current assets | $m | not reported | not reported | [207](/filings/0001564590-21-017439.md) | [594](/filings/0001564590-23-002041.md) | [950](/filings/0001801198-23-000019.md) | [1,099](/filings/0001801198-24-000021.md) | [1,498](/filings/0001801198-25-000012.md) | [1,284](/filings/0001801198-26-000008.md) | [1,247](/filings/0001801198-26-000008.md) |
| Total assets | $m | not reported | not reported | [288](/filings/0001564590-21-017439.md) | [722](/filings/0001564590-23-002041.md) | [1,119](/filings/0001801198-23-000019.md) | [1,331](/filings/0001801198-24-000021.md) | [1,849](/filings/0001801198-25-000012.md) | [1,670](/filings/0001801198-26-000008.md) | [1,734](/filings/0001801198-26-000008.md) |
| Current liabilities | $m | not reported | not reported | [128](/filings/0001564590-21-017439.md) | [116](/filings/0001564590-23-002041.md) | [229](/filings/0001801198-23-000019.md) | [298](/filings/0001801198-24-000021.md) | [216](/filings/0001801198-25-000012.md) | [278](/filings/0001801198-26-000008.md) | [636](/filings/0001801198-26-000008.md) |
| Total liabilities | $m | not reported | not reported | [411](/filings/0001564590-21-017439.md) | [124](/filings/0001564590-23-002041.md) | [354](/filings/0001801198-23-000019.md) | [587](/filings/0001801198-24-000021.md) | [597](/filings/0001801198-25-000012.md) | [630](/filings/0001801198-26-000008.md) | [732](/filings/0001801198-26-000008.md) |
| Shareholders' equity | $m | [12.2](/filings/0001564590-21-017439.md) | [253](/filings/0001564590-23-002041.md) | [(123)](/filings/0001564590-21-017439.md) | [598](/filings/0001564590-23-002041.md) | [766](/filings/0001801198-23-000019.md) | [744](/filings/0001801198-24-000021.md) | [1,251](/filings/0001801198-25-000012.md) | [1,041](/filings/0001801198-25-000012.md) | [1,002](/filings/0001801198-26-000008.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 369,886,369 at 2025-12-31, from the cover of the [20-F filed 2026-03-10](/filings/0001801198-26-000008.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.